Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
Regulatory Impact
|
Mid-range Performer
1210.1000
-31.90
(
-2.57
%)
NSE
May 06, 2025
15:54 PM
52W Low on Apr 07, 2025
Volume:
1.5M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
31 May 2021
Regulatory Impact
1210.10
-2.57%
Annual Report
Annual report for Aurobindo Pharma Ltd. for FY-2021
pdf
More from Aurobindo Pharma Ltd.
Recommended
Market closes lower, Polycab's Q4 net profit beat Forecaster estimates by 17.8%
Trendlyne Marketwatch |
06 May 2025, 03:53PM
IPOs This Week: Ather Energy and Four Other Listings, Plus New Public Issues
|
05 May 2025, 04:52PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020